Recombinant Technologies
Organization
People
Pazhani Sundaram
President and ceo
Sources: reporter.nih.gov
Grants and prizes
R44, Novel Extracorporeal Device 'Amytrapper' To Remove Beta Amyloid In Alzheimer'sDisease, R44AG057327, $625K, 2017–2027, Aug 5, 2025
Sources: reporter.nih.gov